Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients
Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients have?
Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients has 111 citations in the OpenAlex counts ScholarIQ stores.
When was Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients published?
Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients has 1991 year in the ScholarIQ index.
What is the open-access status of Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients?
Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients has bronze oa status in the ScholarIQ index.
What is the DOI of Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients?
The DOI for Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients is on the source record.
What is the PMID of Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients?
The PMID for Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients is on the source record.
What is the OpenAlex record for Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients?
The OpenAlex for Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients is on the source record.